21 May 2009
Detecting anti-donor antibodies by flow cytometry in pediatric kidney transplantation – is it necessary?
B Piątosa, K Siewiera, W Jarmużek, R GrendaAnn Transplant 2009; 14(1): 38-38 :: ID: 880335
Abstract
Background: Immune response after allotransplantation depends on type of transplanted organ, mismatching degree, type of immunosuppression, as well as genetic predisposition of the recipient. Donor-specific antibodies resulting from pre-transplant immunization, as well as produced during response to donor antigens trigger cascade of many events leading to ultimate organ destruction. The purpose of this study was to verify whether we need to apply more sensitive than standard methods to detect antidonor antibodies before transplantation.
Material/Methods: Two hundred and thirteen paediatric patients were transplanted based on negative results of complement dependent cross-match (CDC). Three-color flow cytometric cross-match (FCXM) detecting IgG and IgM antibodies against T and B lymphocytes was performed on sera taken immediately prior to transplantation. Immunosuppression protocol was selected irrespective from results of FCXM. Biopsy-proven rejection rate, graft loss during first month after transplantation, serum creatinine level one and three months after transplantation, as well as median serum creatinine after longest observation period were used to evaluate renal function.
Results: Despite negative results of CDC, antibodies against donor lymphocytes detected by FCXM were found in 21.1% cases, with similar frequency against T and B lymphocytes. Lower relative number of patients with creatinine <1.5 mg/dl and more frequent biopsy-proven rejection were observed among patients with positive FCXM. Early graft loss occurred more frequently among patients with positive FCXM, IgM antibodies or anti-T lymphocyte IgG. Poor renal function one month after transplantation was observed more frequently among patients with antibodies against B lymphocytes or anti-donor lymphocyte IgMs, but no effect of positive FCXM on long-term kidney graft function was observed.
Conclusions: Positive FCXM is an important, although not unique, risk factor of rejection-induced graft loss early after transplantation. Significance of individual correlations can be reduced i.e. by individually tailored immunosuppression regimen.
Keywords: Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






